azathioprine has been researched along with Hematologic Neoplasms in 3 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic immunosuppression is a known risk factor for various malignancies, and azathioprine in particular has been reported in association with solid and hematologic malignancies, including diffuse large B-cell lymphoma." | 8.31 | Primary hepatic Epstein-Barr virus-positive diffuse large B-cell lymphoma associated with azathioprine immunosuppression: a case report. ( Marell, PS; Shi, M; Wingo, MT, 2023) |
| " Chronic immunosuppression is a known risk factor for various malignancies, and azathioprine in particular has been reported in association with solid and hematologic malignancies, including diffuse large B-cell lymphoma." | 4.31 | Primary hepatic Epstein-Barr virus-positive diffuse large B-cell lymphoma associated with azathioprine immunosuppression: a case report. ( Marell, PS; Shi, M; Wingo, MT, 2023) |
| "The frequency of cancer-associated mortality was 11% that was 2% of the total lupus population." | 1.33 | [The occurrence of malignancies in a Hungarian lupus population]. ( Kiss, E; Szegedi, G; Szekanecz, E; Tarr, T; Zeher, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Marell, PS | 1 |
| Shi, M | 1 |
| Wingo, MT | 1 |
| Kari, JA | 1 |
| Trompeter, RS | 1 |
| Tarr, T | 1 |
| Szekanecz, E | 1 |
| Zeher, M | 1 |
| Szegedi, G | 1 |
| Kiss, E | 1 |
1 review available for azathioprine and Hematologic Neoplasms
| Article | Year |
|---|---|
What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Topics: Azathioprine; Calcineurin Inhibitors; Child; Clinical Trials as Topic; Cyclosporine; Growth and Deve | 2004 |
2 other studies available for azathioprine and Hematologic Neoplasms
| Article | Year |
|---|---|
Primary hepatic Epstein-Barr virus-positive diffuse large B-cell lymphoma associated with azathioprine immunosuppression: a case report.
Topics: Azathioprine; Epstein-Barr Virus Infections; Female; Hematologic Neoplasms; Herpesvirus 4, Human; Hu | 2023 |
[The occurrence of malignancies in a Hungarian lupus population].
Topics: Adult; Aged; Azathioprine; Breast Neoplasms; Bronchial Neoplasms; Cyclophosphamide; Female; Gastroin | 2006 |